The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

66183067HM017L0medical innovation,Early HTA,Health Technology

Abstract The role of Health Technology Assessment (HTA) is evolving. Once seen primarily as a gatekeeper, HTA is increasingly viewed as a potential shaper of health system transformation. The first plenary session of the HTA International 2025 Annual Meeting, explored the potential for HTA to ado

Osteoporosis is one of the major public health problems in Thailand, particularly among postmenopausal women and the continuously increasing elderly population. This condition causes a significant disease burden from fractures, leading to patient disability, reduced quality of life, and high expenditures for both the patients themselves and the hea

The development of medical innovation is a key strategic priority of Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a hub for high-value medical and healthcare services. However, despite the continuous growth of medical research in Thailand, many innovations have not successfully progres

Welcome to HTAsiaLink Newsletter, Volume 21!  This year, our network has continued to grow, work together, and share knowledge. From research exchanges and capacity-building activities to policy discussions, our members have shown what can be achieved when we move forward together.  The theme

Thailand’s health system is facing challenges from resource constraints including limited budgets, shortages of health professionals, and restricted access to essential medical equipment. At the same time, the system continues to provide low-value care (LVC), which not only fails to deliver meaningf

EXECUTIVE SUMMARY This annual report has been prepared to compile and summarise the activities of the Health Intervention and Technology Assessment Program (HITAP) projects in the past year (2023). It highlights various initiatives aligned with HITAP’s vision, mission, and strategic pillars, guid

This report provides an overview of regional efforts to strengthen HTA capacity across Southeast Asia under the Association of Southeast Asian Nations (ASEAN) Health Cluster 3 (AHC 3) Work Programme. Led by Health Intervention and Technology Assessment Program Foundation (HITAP), in collaboration

Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H